Raymond James Financial Services Advisors, Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 114 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$21,000
-95.7%
16,538
-94.0%
0.00%
-100.0%
Q3 2020$493,000
-78.4%
273,945
+0.9%
0.00%
-85.7%
Q2 2020$2,279,000
+29.3%
271,585
-19.3%
0.01%
-12.5%
Q1 2020$1,763,000
+6.1%
336,479
+10.6%
0.01%
+60.0%
Q4 2019$1,662,000
+10.5%
304,349
-1.5%
0.01%0.0%
Q3 2019$1,504,000
-28.6%
308,834
+1.7%
0.01%
-37.5%
Q2 2019$2,105,000
-0.6%
303,720
-0.3%
0.01%
-11.1%
Q1 2019$2,118,000
+2.6%
304,683
-13.8%
0.01%
-18.2%
Q4 2018$2,065,000
-32.2%
353,559
-12.4%
0.01%
-21.4%
Q3 2018$3,046,000
+40.9%
403,445
-5.7%
0.01%
+27.3%
Q2 2018$2,162,000
-16.5%
428,026
+0.8%
0.01%
-26.7%
Q1 2018$2,589,000
-16.2%
424,478
-2.4%
0.02%
-21.1%
Q4 2017$3,089,000
-2.8%
435,024
-2.1%
0.02%
-5.0%
Q3 2017$3,178,000
+18.3%
444,504
+4.3%
0.02%
+5.3%
Q2 2017$2,686,000
-19.4%
426,280
+5.5%
0.02%
-24.0%
Q1 2017$3,332,000
+3.0%
403,886
+5.5%
0.02%
-7.4%
Q4 2016$3,234,000
+32.4%
382,761
+6.4%
0.03%
+22.7%
Q3 2016$2,443,000
+208.5%
359,761
+35.9%
0.02%
+175.0%
Q2 2016$792,000
+59.4%
264,753
-3.7%
0.01%
+33.3%
Q1 2016$497,000
+114.2%
274,840
+95.4%
0.01%
+100.0%
Q4 2015$232,000140,6620.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders